Skip to content
Research Article Open access CC BY 4.0

Combined Intralipid-urotherapy for Patients with Cancer: A Creative Review

Joseph Eldor

Journal of Cancer and Tumor International · pp. 1–31 · Published 8 May 2017

10.9734/JCTI/2017/32940

Abstract

The article relates in general to intralipid and its use in cancer therapy. Specifically, it relates to the combined intralipid-urotherapy for treating cancer, and methods of such treatment. Cancer cells release various antigens, some of which appear in the urine. Combined oral Intralipid and auto-urotherapy is suggested as a new treatment modality for cancer patients. It will provide the intestinal lymphatic system the many tumor antigens against which antibodies may be produced. These antibodies may be transpierced through the blood stream and attack the tumor and its cells. Intralipid can increase the response to the cancer antigens in the intestinal lymphatic system against which antibodies may be produced.  

Cancer auto- urotherapy intralipid

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.